Article info
PDFOriginal research
Symptom interval and treatment burden for patients with malignant central nervous system germ cell tumours
- Correspondence to Dr Matthew J Murray, Department of Paediatric Haematology and Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK; mjm16{at}cam.ac.uk
Citation
Symptom interval and treatment burden for patients with malignant central nervous system germ cell tumours
Publication history
- Received March 17, 2019
- Revised September 2, 2019
- Accepted September 23, 2019
- First published October 8, 2019.
Online issue publication
May 23, 2021
Article Versions
- Previous version (23 May 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.